Additional file 1: Table S1. of Use of low density lipoprotein particle number levels as an aid in statin treatment decisions for intermediate risk patients: a cost-effectiveness analysis

Health outcomes and costs for different statin treatment strategies for primary prevention of cardiovascular disease in 100,000 hypothetical intermediate risk patients: Base-case analysis. Table S2. Deterministic Sensitivity Analysis. Incremental Cost and Incremental QALY per 100,000 patients for all parameters for the Test and HST strategy 1 compared with the MST strategy. Table S3. Deterministic Sensitivity Analysis. Incremental Cost and Incremental QALY per 100,000 patients for all parameters for the Test and MST strategy 1 compared with the Do-Not-Treat strategy. Table S4. Deterministic Sensitivity Analysis Incremental Cost and Incremental QALY per 100,000 patients for all parameters for the HST strategy compared 1 with the MST strategy. (DOCX 67 kb)